- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Somatic drivers of B-ALL in a model of ETV6-RUNX1; Pax5 +/− leukemia ; volume:15 ; number:1 ; day:13 ; month:8 ; year:2015 ; pages:1-6 ; date:12.2015
BMC cancer ; 15, Heft 1 (13.8.2015), 1-6, 12.2015
- Creator
-
van der Weyden, Louise
- Contributor
-
Giotopoulos, George
Wong, Kim
Rust, Alistair G.
Robles-Espinoza, Carla Daniela
Osaki, Hikari
Huntly, Brian J.
Adams, David J.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1586-1
- URN
-
urn:nbn:de:1111-2016110620408
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- van der Weyden, Louise
- Giotopoulos, George
- Wong, Kim
- Rust, Alistair G.
- Robles-Espinoza, Carla Daniela
- Osaki, Hikari
- Huntly, Brian J.
- Adams, David J.
- SpringerLink (Online service)
Other Objects (12)
RUNX1 mutations in acute myeloid leukemia
P335: Genomic determinants of therapy response in ETV6-RUNX1 leukemia
Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia
RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
Somatic evolutionary timings of driver mutations
Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia
The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?
Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia
RUNX1 gene expression in Egyptian acute myeloid leukemia patients: may it have therapeutic implications?
miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia
ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol
RUNX1 mutations in acute myeloid leukemia
P335: Genomic determinants of therapy response in ETV6-RUNX1 leukemia
Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia
RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
Somatic evolutionary timings of driver mutations
Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia
The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?
Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia
RUNX1 gene expression in Egyptian acute myeloid leukemia patients: may it have therapeutic implications?
miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia
ETV6/RUNX1-positive childhood acute lymphoblastic leukemia in China: excellent prognosis with improved BFM protocol
RUNX1 mutations in acute myeloid leukemia
P335: Genomic determinants of therapy response in ETV6-RUNX1 leukemia
Monitoring Minimal Residual Disease in RUNX1 -Mutated Acute Myeloid Leukemia
RUNX1 mutations promote leukemogenesis of myeloid malignancies in ASXL1-mutated leukemia
Somatic evolutionary timings of driver mutations
Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia
The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia
ETV6::RUNX1 Acute Lymphoblastic Leukemia: how much therapy is needed for cure?
Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia
RUNX1 gene expression in Egyptian acute myeloid leukemia patients: may it have therapeutic implications?
miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia